Brief communication: efficacy and safety of the dolutegravir/lamivudine dual therapy in antiretroviral treatment-experienced Chinese people living with HIV

Abstract This study aimed to evaluate the efficacy and safety of dolutegravir plus lamivudine (DTG/3TC) in antiretroviral treatment (ART)-experienced people living with HIV (PLWH). A total of 303 PLWH in Shanghai, China, who switched from triple ART to DTG/3TC between January 2019 and June 2022, wit...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Zhenyan Wang, Junyang Yang, Lin Wang, Jiangrong Wang, Yinzhong Shen, Jun Chen, Tangkai Qi, Jianjun Sun, Wei Song, Yang Tang, Shuibao Xu, Li Liu, Renfang Zhang
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	BMC 2024-11-01
Cyfres:	AIDS Research and Therapy
Pynciau:	HIV Dolutegravir Lamivudine Antiretroviral
Mynediad Ar-lein:	https://doi.org/10.1186/s12981-024-00680-x
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!